Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source. 

Department of Defense Breast Cancer Research Program Funding Opportunities

These funding opps are to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public.  

Breakthrough Award – Level 1 & 2: The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. Letter of Intent Due: March 14, 2019
Breakthrough Fellowship Award: The Fellowship Award supports recent doctoral or medical graduates in pursuit of innovative, high-impact breast cancer research during their postdoctoral fellowship. Letter of Intent Due: March 14, 2019
Era of Hope Scholar Award: The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. Letter of Intent Due: March 14, 2019

Sontag Foundation  Distinguished Scientist Award

The DSA seeks to provide career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research.

Application Deadline: March 13, 2019

INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21)

This FOA invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in Down syndrome.

Application Deadline: March 14, 2019

Transformative Research Award for the INCLUDE Project (R01)

This RFA seeks to support individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies.

Application Deadline: March 14, 2019

Clinical Trials Development for INCLUDE (R61/R33

This FOA encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome.

Application Deadline: March 14, 2019

Damon Runyon Cancer Research Foundation Fellowship Award

The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor.

Application Deadline: March 15, 2019

NCCN Preclinical and Clinical Studies of CDK4 and 6 Inhibition with Abemaciclib for Breast Cancers

NCCN has received a $2 million research grant from Eli Lilly and Company to support the performance of preclinical, clinical and correlative studies of abemaciclib in the treatment of breast cancer.

RFP Due: March 22, 2019

Charles H. Hood Foundation Child Health Research Awards Program

The intent of this Award is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of funding. Research projects must have direct relevance to child health.

Application Deadline: March 28, 2019 

NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5)

The overarching goal of this NCI UE5 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical cancer research needs.

Application Deadline: April 1, 2019

Learn more about the NCI Skill Development Courses>>

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44)

This FOA encourages Small Business Innovation Research grant applications from small business concerns proposing research for commercial development of novel cancer-relevant technologies.

Application Deadline: April 5, 2019

View the SBIR grant application>>

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44)

This FOA encourages Small Business Innovation Research grant applications from small business concerns proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries, and low-resource settings in the US.

Application Deadline: April 5, 2019

Request for Information to Better Facilitate Cancer Systems Epidemiology Research

The NCI seeks broad input from members of the scientific community to identify areas of need and opportunities for interdisciplinary, systems science research focused on cancer risk and prognosis, particularly data analysis and interpretation when applying comprehensive analytical approaches, such as systems or computational modeling, to study of the etiology of cancer.  

Response Date: April 30 , 2019

Biology of Bladder Cancer (R01/R21)

This FOA encourages applications investigating the biology and underlying mechanisms of bladder cancer.

Application Deadlines: (R01): June 5, 2019 (R21): June 16, 2019

Tobacco Regulatory Science (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health.

Estimated Application Due Date: July 19, 2019

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)

The purpose of this FOA is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or AIDS.

Application Deadline: August 1, 2019

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants. 

Current opportunities are listed below. 

View a full list of grant opportunities available throughout the year>> 

YCCI Scholar Award

We are pleased to announce a request for applications for YCCI Scholar Awards, which provide salary and/or research funds to a select number of junior faculty members who are strongly committed to careers in clinical research, community-based research or translational research. Translational research includes basic science studies that are related to human disease, including studies that utilize animal models or in vitro studies such as cell cultures. The primary aim of these awards is to prepare the applicant for successful independent research careers, and emphasis will be placed on career development and mentoring plans. Awards will be for a total of 2 years.

Letter of Intent Deadline: April 12, 2019

YCCI Clinical Junior Faculty Pilot

YCCI invites applications from Yale clinical junior faculty. This award is intended to support junior clinician educator faculty who are interested in developing research as a component of their academic life. We anticipate the awardees will be very active clinicians, who would benefit from a period of protected time and resources to pursue research ideas. The primary aim of these awards is to provide early career pilot support and to allow a career trajectory which successfully integrates clinical care and research. An emphasis will be placed on career development and mentoring plans, by successful senior clinical faculty capable of understanding the challenges of integrating very active clinical care with a robust translational research portfolio.

Letter of Intent Deadline: April 12, 2019

Luminary Award of Excellence

The YNHH Smilow Luminary Award of Excellence will serve to recognize, and ceremoniously acknowledge, those individuals and/or teams who consistently exceed performance expectations and deliver high quality cancer care for our patients, families and the health system through community service, optimization/ innovative solutions, patient experience, leadership and research initiatives. Nominations should be submitted directly to